PepGen Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Research and development | $71.0M | $76.5M | $68.1M | $54.1M | $19.0M |
| Operating expenses | $93.6M | $97.7M | $84.8M | $68.3M | $27.1M |
| Operating income | -$93.6M | -$97.7M | -$84.8M | -$68.3M | -$27.1M |
| Pretax income | -$89.6M | -$90.6M | -$78.6M | -$65.4M | -$27.3M |
| Income tax expense | $48,865 | -$617,000 | $73,000 | $3.7M | $0 |
| Net income | -$89.7M | -$90.0M | -$78.6M | -$69.1M | -$27.3M |
| Balance Sheet | |||||
| Cash and equivalents | $60.5M | $49.4M | $80.8M | $181.8M | $132.9M |
| Current assets | $151.0M | $123.8M | $112.7M | $186.1M | $140.0M |
| Total assets | $173.9M | $150.9M | $143.1M | $217.4M | $143.6M |
| Current liabilities | $12.6M | $16.7M | $17.5M | $18.8M | $10.3M |
| Total liabilities | $26.5M | $32.3M | $34.6M | $37.8M | $10.5M |
| Stockholders' equity | $147.4M | $118.6M | $108.4M | $179.6M | -$32.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$81.6M | -$82.4M | -$69.0M | -$59.3M | -$22.6M |
| Depreciation and amortization | $1.4M | $1.5M | $1.2M | $500,000 | $200,000 |
| Stock-based compensation | $10.6M | $11.5M | $7.0M | $4.8M | $1.5M |
| Capital expenditure | $264,000 | $497,000 | $2.6M | $3.8M | $500,000 |
| Free cash flow | -$81.9M | -$82.9M | -$71.6M | -$63.0M | -$23.1M |
Shares outstanding 69.2M · Free float 62.3%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.